Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Roth Capital biotech analysts to hold an analyst/industry conference call » 14:25
05/26/20
05/26
14:25
05/26/20
14:25
AKRO

Akero Therapeutics

$24.92 /

+0.71 (+2.93%)

, ALT

Altimmune

$8.45 /

+1.51 (+21.76%)

, ENTA

Enanta

$55.90 /

+0.78 (+1.42%)

, GLMD

Galmed

$5.51 /

-0.29 (-5.00%)

, GNFT

Genfit

$5.26 /

+0.02 (+0.38%)

, HEPA

Hepion Pharmaceuticals

$1.94 /

-0.05 (-2.51%)

, ICPT

Intercept

$77.59 /

-2.95 (-3.66%)

, MDGL

Madrigal Pharmaceuticals

$123.16 /

-2.67 (-2.12%)

, NGM

NGM Biopharmaceuticals

$21.22 /

+1.04 (+5.15%)

Biotech Analysts, along…

Biotech Analysts, along with Dr. Eric Lawitz, discuss Non-Alcoholic SteatoHepatitis (NASH) on an Analyst/Industry conference call to be held on May 26 at 3 pm.

ShowHide Related Items >><<
NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

HEPA Hepion Pharmaceuticals
$1.94 /

-0.05 (-2.51%)

GNFT Genfit
$5.26 /

+0.02 (+0.38%)

ENTA Enanta
$55.90 /

+0.78 (+1.42%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/02/20 H.C. Wainwright
Akero Therapeutics initiated with a Buy at H.C. Wainwright
02/13/20 Roth Capital
Akero Therapeutics price target raised to $43 from $34 at Roth Capital
02/10/20 Canaccord
Akero Therapeutics initiated with a Buy at Canaccord
ALT Altimmune
$8.45 /

+1.51 (+21.76%)

05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
02/24/20
Fly Intel: Top five analyst initiations
ENTA Enanta
$55.90 /

+0.78 (+1.42%)

03/17/20 Baird
Baird upgrades 'defensive' Enanta, sees 'real COVID-19 potential'
03/17/20 Baird
Enanta upgraded to Outperform from Neutral at Baird
02/07/20 Roth Capital
Enanta is 'undervalued and underappreciated,' says Roth Capital
11/22/19
Fly Intel: Top five analyst downgrades
GLMD Galmed
$5.51 /

-0.29 (-5.00%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley FBR
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley FBR
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
GNFT Genfit
$5.26 /

+0.02 (+0.38%)

05/22/20 B. Riley FBR
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/13/20 Bryan Garnier
Genfit downgraded to Neutral from Buy at Bryan Garnier
05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
HEPA Hepion Pharmaceuticals
$1.94 /

-0.05 (-2.51%)

03/20/20 Roth Capital
Roth Capital says Hepion's CRV431 could be used in COVID-19 treatment
11/22/19 Brookline
Hepion Pharmaceuticals initiated with a Buy at Brookline
11/07/19
Fly Intel: Top analyst initiations
11/07/19 Roth Capital
Hepion Pharmaceuticals initiated with a Buy at Roth Capital
ICPT Intercept
$77.59 /

-2.95 (-3.66%)

05/22/20 B. Riley FBR
Intercept weakness on 'slight' delay should be bought, says B. Riley FBR
05/22/20 Raymond James
Intercept downgraded at Raymond James after OCA NDA is postponed
05/22/20 Raymond James
Intercept downgraded to Outperform from Strong Buy at Raymond James
05/22/20 Stifel
Intercept uncertainty, lack of clarity in NASH to hurt sentiment, says Stifel
MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Chardan
Madrigal Pharmaceuticals initiated with a Buy at Chardan
NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/27/20 Citi
NGM Biopharmaceuticals price target lowered to $28 from $34 at Citi
NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

GLMD Galmed
$5.51 /

-0.29 (-5.00%)

ENTA Enanta
$55.90 /

+0.78 (+1.42%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

GNFT Genfit
$5.26 /

+0.02 (+0.38%)

NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

GNFT Genfit
$5.26 /

+0.02 (+0.38%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

Conference/Events
Roth Capital biotech analysts to hold an analyst/industry conference call » 09:42
05/26/20
05/26
09:42
05/26/20
09:42
AKRO

Akero Therapeutics

$24.21 /

+ (+0.00%)

, ALT

Altimmune

$6.94 /

+ (+0.00%)

, ENTA

Enanta

$55.12 /

+ (+0.00%)

, GLMD

Galmed

$5.80 /

+ (+0.00%)

, GNFT

Genfit

$5.24 /

+ (+0.00%)

, HEPA

Hepion Pharmaceuticals

$1.99 /

+ (+0.00%)

, ICPT

Intercept

$80.54 /

+ (+0.00%)

, MDGL

Madrigal Pharmaceuticals

$125.83 /

+ (+0.00%)

, NGM

NGM Biopharmaceuticals

$20.18 /

+ (+0.00%)

Biotech Analysts, along…

Biotech Analysts, along with Dr. Eric Lawitz, discuss Non-Alcoholic SteatoHepatitis (NASH) on an Analyst/Industry conference call to be held on May 26 at 3 pm.

ShowHide Related Items >><<
NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

HEPA Hepion Pharmaceuticals
$1.99 /

+ (+0.00%)

GNFT Genfit
$5.24 /

+ (+0.00%)

ENTA Enanta
$55.12 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/02/20 H.C. Wainwright
Akero Therapeutics initiated with a Buy at H.C. Wainwright
02/13/20 Roth Capital
Akero Therapeutics price target raised to $43 from $34 at Roth Capital
02/10/20 Canaccord
Akero Therapeutics initiated with a Buy at Canaccord
ALT Altimmune
$6.94 /

+ (+0.00%)

05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
02/24/20
Fly Intel: Top five analyst initiations
ENTA Enanta
$55.12 /

+ (+0.00%)

03/17/20 Baird
Baird upgrades 'defensive' Enanta, sees 'real COVID-19 potential'
03/17/20 Baird
Enanta upgraded to Outperform from Neutral at Baird
02/07/20 Roth Capital
Enanta is 'undervalued and underappreciated,' says Roth Capital
11/22/19
Fly Intel: Top five analyst downgrades
GLMD Galmed
$5.80 /

+ (+0.00%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley FBR
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley FBR
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
GNFT Genfit
$5.24 /

+ (+0.00%)

05/22/20 B. Riley FBR
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/13/20 Bryan Garnier
Genfit downgraded to Neutral from Buy at Bryan Garnier
05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
HEPA Hepion Pharmaceuticals
$1.99 /

+ (+0.00%)

03/20/20 Roth Capital
Roth Capital says Hepion's CRV431 could be used in COVID-19 treatment
11/22/19 Brookline
Hepion Pharmaceuticals initiated with a Buy at Brookline
11/07/19
Fly Intel: Top analyst initiations
11/07/19 Roth Capital
Hepion Pharmaceuticals initiated with a Buy at Roth Capital
ICPT Intercept
$80.54 /

+ (+0.00%)

05/22/20 B. Riley FBR
Intercept weakness on 'slight' delay should be bought, says B. Riley FBR
05/22/20 Raymond James
Intercept downgraded at Raymond James after OCA NDA is postponed
05/22/20 Raymond James
Intercept downgraded to Outperform from Strong Buy at Raymond James
05/22/20 Stifel
Intercept uncertainty, lack of clarity in NASH to hurt sentiment, says Stifel
MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Chardan
Madrigal Pharmaceuticals initiated with a Buy at Chardan
NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/27/20 Citi
NGM Biopharmaceuticals price target lowered to $28 from $34 at Citi
NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

GLMD Galmed
$5.80 /

+ (+0.00%)

ENTA Enanta
$55.12 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

GNFT Genfit
$5.24 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

GNFT Genfit
$5.24 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

Friday
Recommendations
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR » 08:54
05/22/20
05/22
08:54
05/22/20
08:54
MDGL

Madrigal Pharmaceuticals

$119.46 /

-2.52 (-2.07%)

, GNFT

Genfit

$5.26 /

-0.16 (-2.95%)

B. Riley FBR analyst…

B. Riley FBR analyst Mayank Mamtani raised the firm's price target on Madrigal Pharmaceuticals (MDGL) to $174 from $134 and keeps a Buy rating on the shares. After hosting a call with Dr. Stephen Harrison from Pinnacle Clinical Research on recent advances in clinical development of therapeutics in non-alcoholic steatohepatitis, the analyst believes the high placebo response in Genfit's (GNFT) Phase III trial is bullish for Madrigal.

ShowHide Related Items >><<
MDGL Madrigal Pharmaceuticals
$119.46 /

-2.52 (-2.07%)

GNFT Genfit
$5.26 /

-0.16 (-2.95%)

MDGL Madrigal Pharmaceuticals
$119.46 /

-2.52 (-2.07%)

05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Chardan
Madrigal Pharmaceuticals initiated with a Buy at Chardan
03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
GNFT Genfit
$5.26 /

-0.16 (-2.95%)

05/13/20 Bryan Garnier
Genfit downgraded to Neutral from Buy at Bryan Garnier
05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
MDGL Madrigal Pharmaceuticals
$119.46 /

-2.52 (-2.07%)

GNFT Genfit
$5.26 /

-0.16 (-2.95%)

MDGL Madrigal Pharmaceuticals
$119.46 /

-2.52 (-2.07%)

GNFT Genfit
$5.26 /

-0.16 (-2.95%)

Over a week ago
Downgrade
Genfit downgraded to Neutral from Buy at Bryan Garnier » 05:26
05/13/20
05/13
05:26
05/13/20
05:26
GNFT

Genfit

$7.09 /

-15.08 (-68.02%)

Bryan Garnier analyst…

Bryan Garnier analyst Jean-Jacques Le Fur downgraded Genfit to Neutral from Buy with a price target of EUR 11, down from EUR 60. The analyst says the company needs to find a new direction following the failure of elafibranor in nonalcoholic steatohepatitis.

ShowHide Related Items >><<
GNFT Genfit
$7.09 /

-15.08 (-68.02%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
GNFT Genfit
$7.09 /

-15.08 (-68.02%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

Downgrade
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux » 05:23
05/13/20
05/13
05:23
05/13/20
05:23
GNFT

Genfit

$7.09 /

-15.08 (-68.02%)

Kepler Cheuvreux analyst…

Kepler Cheuvreux analyst Arsene Guekam double downgraded Genfit to Reduce from Buy with a EUR 6 price target.

ShowHide Related Items >><<
GNFT Genfit
$7.09 /

-15.08 (-68.02%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
05/12/20 SVB Leerink
Genfit price target lowered to $20 from $50 at SVB Leerink
GNFT Genfit
$7.09 /

-15.08 (-68.02%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 17:01
05/12/20
05/12
17:01
05/12/20
17:01
GRUB

GrubHub

$60.39 /

+13.57 (+28.98%)

, UBER

Uber

$32.38 /

+0.73 (+2.31%)

, PNC

PNC Financial

$100.00 /

-2.26 (-2.21%)

, BLK

BlackRock

$454.17 /

-39.27 (-7.96%)

, RF

Regions Financial

$9.33 /

-0.485 (-4.94%)

, CMA

Comerica

$30.51 /

-1.64 (-5.10%)

, KEY

KeyCorp

$10.17 /

-0.54 (-5.04%)

, FITB

Fifth Third

$16.29 /

-0.92 (-5.35%)

, CBAY

CymaBay

$4.21 /

+2.37 (+128.80%)

, GNFT

Genfit

$7.09 /

-15.08 (-68.02%)

, TSLA

Tesla

$809.35 /

-1.46 (-0.18%)

, OKE

Oneok

$32.97 /

+1.59 (+5.07%)

, MRO

Marathon Oil

$5.96 /

+0.215 (+3.74%)

, DVN

Devon Energy

$12.41 /

-0.05 (-0.40%)

, AMCR

Amcor

$9.11 /

+0.285 (+3.23%)

, GDOT

Green Dot

$34.84 /

+4.06 (+13.19%)

, EB

Eventbrite

$8.05 /

-2.46 (-23.41%)

, GSKY

GreenSky

$3.62 /

-0.85 (-19.02%)

Stocks slid as investors…

Open Full Text

ShowHide Related Items >><<
UBER Uber
$32.38 /

+0.73 (+2.31%)

TSLA Tesla
$809.35 /

-1.46 (-0.18%)

RF Regions Financial
$9.33 /

-0.485 (-4.94%)

PNC PNC Financial
$100.00 /

-2.26 (-2.21%)

OKE Oneok
$32.97 /

+1.59 (+5.07%)

MRO Marathon Oil
$5.96 /

+0.215 (+3.74%)

KEY KeyCorp
$10.17 /

-0.54 (-5.04%)

GSKY GreenSky
$3.62 /

-0.85 (-19.02%)

GRUB GrubHub
$60.39 /

+13.57 (+28.98%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

GDOT Green Dot
$34.84 /

+4.06 (+13.19%)

FITB Fifth Third
$16.29 /

-0.92 (-5.35%)

EB Eventbrite
$8.05 /

-2.46 (-23.41%)

DVN Devon Energy
$12.41 /

-0.05 (-0.40%)

CMA Comerica
$30.51 /

-1.64 (-5.10%)

CBAY CymaBay
$4.21 /

+2.37 (+128.80%)

BLK BlackRock
$454.17 /

-39.27 (-7.96%)

GRUB GrubHub
$60.39 /

+13.57 (+28.98%)

05/13/20 DA Davidson
GrubHub may hold off for better price than Uber offers, DA Davidson says
05/13/20 Northcoast
GrubHub deal would make Uber Eats 'less bad,' says Northcoast
05/13/20 Jefferies
Jefferies says high end of past food delivery deals values GrubHub near $70
05/13/20 Guggenheim
GrubHub deal price reportedly discussed below Guggenheim's prior 'best case'
UBER Uber
$32.38 /

+0.73 (+2.31%)

PNC PNC Financial
$100.00 /

-2.26 (-2.21%)

05/12/20 Stephens
PNC Financial upgraded to Overweight from Equal Weight at Stephens
05/04/20 UBS
Wells Fargo, PNC Financial cut to Sell, Keycorp cut to Neutral at UBS
05/04/20 UBS
PNC Financial downgraded to Sell from Neutral at UBS
04/16/20 Nomura Instinet
PNC Financial upgraded to Buy from Neutral at Nomura Instinet
BLK BlackRock
$454.17 /

-39.27 (-7.96%)

04/17/20 BMO Capital
BlackRock price target raised to $441 from $386 at BMO Capital
04/17/20 Barclays
BlackRock price target raised to $515 from $495 at Barclays
04/08/20 Morgan Stanley
Victory Capital downgraded to Underweight at Morgan Stanley
RF Regions Financial
$9.33 /

-0.485 (-4.94%)

04/14/20 Compass Point
Regions Financial initiated with a Neutral at Compass Point
03/19/20 Goldman Sachs
Regions Financial upgraded to Conviction Buy from Buy at Goldman Sachs
03/17/20 Wedbush
Regions Financial added to Best List Ideas at Wedbush
03/09/20 Raymond James
Regions Financial double downgraded at Raymond James as oil prices sink
CMA Comerica
$30.51 /

-1.64 (-5.10%)

04/14/20 Compass Point
Comerica initiated with a Neutral at Compass Point
04/06/20 Wells Fargo
Wells Fargo sees information 'void' until banks report earnings next week
03/26/20 Odeon Capital
Comerica upgraded to Hold from Sell at Odeon Capital
03/19/20 SunTrust
Comerica price target lowered to $40 from $52 at SunTrust
KEY KeyCorp
$10.17 /

-0.54 (-5.04%)

05/04/20 UBS
KeyCorp downgraded to Neutral from Buy at UBS
04/17/20 BofA
KeyCorp downgraded to Neutral from Buy at BofA
04/17/20 BofA
KeyCorp downgraded to Neutral from Buy at BofA
FITB Fifth Third
$16.29 /

-0.92 (-5.35%)

03/23/20 DA Davidson
Fifth Third initiated with a Buy at DA Davidson
03/18/20 Wedbush
Fifth Third/Toll Brothers/Tempur Sealy removed from Best Ideas List at Wedbush
03/02/20 Baird
Baird upgrades Regions Financial, Fifth Third, First Horizon to Outperform
CBAY CymaBay
$4.21 /

+2.37 (+128.80%)

05/12/20 B. Riley FBR
CymaBay upgraded to Buy from Neutral at B. Riley FBR
05/12/20
Fly Intel: Top five analyst upgrades
05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
05/12/20 SVB Leerink
CymaBay upgraded to Outperform at SVB Leerink
GNFT Genfit
$7.09 /

-15.08 (-68.02%)

05/13/20 Bryan Garnier
Genfit downgraded to Neutral from Buy at Bryan Garnier
05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
TSLA Tesla
$809.35 /

-1.46 (-0.18%)

05/12/20 Wedbush
'Standoff at Fremont' begins as Tesla's Musk restarts engines, says Wedbush
05/11/20 Deutsche Bank
Tesla reiterated order backlog continues to grow, says Deutsche Bank
05/11/20 Wedbush
Moving away from Fremont could add risk to Tesla manufacturing, says Wedbush
05/07/20 Roth Capital
Tesla's reported suspension in Shanghai adds downside risk, says Roth Capital
OKE Oneok
$32.97 /

+1.59 (+5.07%)

05/13/20 UBS
Oneok downgraded to Neutral from Buy at UBS
05/05/20
Fly Intel: Top five analyst downgrades
05/05/20 Credit Suisse
Oneok downgraded to Neutral from Outperform at Credit Suisse
05/01/20 Mizuho
Oneok price target lowered to $36 from $41 at Mizuho
MRO Marathon Oil
$5.96 /

+0.215 (+3.74%)

05/08/20 Susquehanna
Marathon Oil downgraded to Neutral at Susquehanna
05/08/20 Susquehanna
Marathon Oil downgraded to Neutral from Positive at Susquehanna
04/22/20 Credit Suisse
Marathon Oil downgraded to Neutral from Outperform at Credit Suisse
04/15/20 OTR Global
U.S. tank barge shipping market view lowered to mixed at OTR Global
DVN Devon Energy
$12.41 /

-0.05 (-0.40%)

05/06/20 Susquehanna
Devon Energy price target raised to $13 from $12 at Susquehanna
03/25/20 Piper Sandler
Devon Energy downgraded to Neutral from Overweight at Piper Sandler
03/24/20 Piper Sandler
Devon Energy downgraded to Neutral from Overweight at Piper Sandler
03/24/20 SunTrust
Devon Energy price target lowered to $8 from $15 at SunTrust
AMCR Amcor
$9.11 /

+0.285 (+3.23%)

04/23/20 Jefferies
Amcor downgraded to Hold from Buy at Jefferies
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
04/02/20 Deutsche Bank
Amcor price target raised to $9.25 from $7.50 at Deutsche Bank
03/23/20 Jefferies
Amcor upgraded to Buy from Hold at Jefferies
GDOT Green Dot
$34.84 /

+4.06 (+13.19%)

05/12/20 SunTrust
Green Dot price target raised to $50 from $40 at SunTrust
05/12/20 Craig-Hallum
Green Dot price target raised to $42 from $35 at Craig-Hallum
05/12/20 Needham
Green Dot price target raised to $40 from $30 at Needham
05/12/20 BTIG
Green Dot price target raised to $40 from $35 at BTIG
EB Eventbrite
$8.05 /

-2.46 (-23.41%)

05/12/20 SunTrust
Eventbrite price target raised to $12 from $8 at SunTrust
04/03/20 SunTrust
Eventbrite price target lowered to $8 from $19 at SunTrust
02/28/20 SunTrust
Eventbrite price target lowered to $19 from $22 at SunTrust
02/28/20 RBC Capital
Eventbrite downgraded to Sector Perform from Outperform at RBC Capital
GSKY GreenSky
$3.62 /

-0.85 (-19.02%)

05/13/20 SunTrust
GreenSky price target lowered to $4 from $7 at SunTrust
05/13/20 Citi
GreenSky price target lowered to $3.50 from $4.50 at Citi
03/18/20 Citi
GreenSky downgraded to Sell from Neutral at Citi
08/08/19 Raymond James
GreenSky downgraded to Market Perform after weak Q2, says Raymond James
UBER Uber
$32.38 /

+0.73 (+2.31%)

TSLA Tesla
$809.35 /

-1.46 (-0.18%)

RF Regions Financial
$9.33 /

-0.485 (-4.94%)

PNC PNC Financial
$100.00 /

-2.26 (-2.21%)

OKE Oneok
$32.97 /

+1.59 (+5.07%)

MRO Marathon Oil
$5.96 /

+0.215 (+3.74%)

KEY KeyCorp
$10.17 /

-0.54 (-5.04%)

GSKY GreenSky
$3.62 /

-0.85 (-19.02%)

GRUB GrubHub
$60.39 /

+13.57 (+28.98%)

GDOT Green Dot
$34.84 /

+4.06 (+13.19%)

FITB Fifth Third
$16.29 /

-0.92 (-5.35%)

EB Eventbrite
$8.05 /

-2.46 (-23.41%)

DVN Devon Energy
$12.41 /

-0.05 (-0.40%)

CMA Comerica
$30.51 /

-1.64 (-5.10%)

CBAY CymaBay
$4.21 /

+2.37 (+128.80%)

BLK BlackRock
$454.17 /

-39.27 (-7.96%)

AMCR Amcor
$9.11 /

+0.285 (+3.23%)

  • 13
    May
TSLA Tesla
$809.35 /

-1.46 (-0.18%)

RF Regions Financial
$9.33 /

-0.485 (-4.94%)

PNC PNC Financial
$100.00 /

-2.26 (-2.21%)

MRO Marathon Oil
$5.96 /

+0.215 (+3.74%)

KEY KeyCorp
$10.17 /

-0.54 (-5.04%)

GRUB GrubHub
$60.39 /

+13.57 (+28.98%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

FITB Fifth Third
$16.29 /

-0.92 (-5.35%)

EB Eventbrite
$8.05 /

-2.46 (-23.41%)

DVN Devon Energy
$12.41 /

-0.05 (-0.40%)

CMA Comerica
$30.51 /

-1.64 (-5.10%)

BLK BlackRock
$454.17 /

-39.27 (-7.96%)

AMCR Amcor
$9.11 /

+0.285 (+3.23%)

UBER Uber
$32.38 /

+0.73 (+2.31%)

TSLA Tesla
$809.35 /

-1.46 (-0.18%)

RF Regions Financial
$9.33 /

-0.485 (-4.94%)

PNC PNC Financial
$100.00 /

-2.26 (-2.21%)

OKE Oneok
$32.97 /

+1.59 (+5.07%)

MRO Marathon Oil
$5.96 /

+0.215 (+3.74%)

KEY KeyCorp
$10.17 /

-0.54 (-5.04%)

GSKY GreenSky
$3.62 /

-0.85 (-19.02%)

GRUB GrubHub
$60.39 /

+13.57 (+28.98%)

GNFT Genfit
$7.09 /

-15.08 (-68.02%)

GDOT Green Dot
$34.84 /

+4.06 (+13.19%)

FITB Fifth Third
$16.29 /

-0.92 (-5.35%)

DVN Devon Energy
$12.41 /

-0.05 (-0.40%)

CMA Comerica
$30.51 /

-1.64 (-5.10%)

CBAY CymaBay
$4.21 /

+2.37 (+128.80%)

BLK BlackRock
$454.17 /

-39.27 (-7.96%)

UBER Uber
$32.38 /

+0.73 (+2.31%)

TSLA Tesla
$809.35 /

-1.46 (-0.18%)

RF Regions Financial
$9.33 /

-0.485 (-4.94%)

PNC PNC Financial
$100.00 /

-2.26 (-2.21%)

OKE Oneok
$32.97 /

+1.59 (+5.07%)

MRO Marathon Oil
$5.96 /

+0.215 (+3.74%)

KEY KeyCorp
$10.17 /

-0.54 (-5.04%)

GSKY GreenSky
$3.62 /

-0.85 (-19.02%)

GRUB GrubHub
$60.39 /

+13.57 (+28.98%)

FITB Fifth Third
$16.29 /

-0.92 (-5.35%)

EB Eventbrite
$8.05 /

-2.46 (-23.41%)

DVN Devon Energy
$12.41 /

-0.05 (-0.40%)

BLK BlackRock
$454.17 /

-39.27 (-7.96%)

TSLA Tesla
$809.35 /

-1.46 (-0.18%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:54
05/12/20
05/12
12:54
05/12/20
12:54
GRUB

GrubHub

$62.52 /

+15.7 (+33.53%)

, UBER

Uber

$33.66 /

+2.005 (+6.33%)

, PNC

PNC Financial

$100.09 /

-2.17 (-2.12%)

, BLK

BlackRock

$464.17 /

-29.27 (-5.93%)

, RF

Regions Financial

$9.69 /

-0.12 (-1.22%)

, CMA

Comerica

$31.32 /

-0.83 (-2.58%)

, KEY

KeyCorp

$10.54 /

-0.17 (-1.59%)

, FITB

Fifth Third

$16.69 /

-0.52 (-3.02%)

, CBAY

CymaBay

$4.28 /

+2.44 (+132.61%)

, GNFT

Genfit

$7.54 /

-14.63 (-65.99%)

, OKE

Oneok

$33.81 /

+2.43 (+7.74%)

, MRO

Marathon Oil

$6.18 /

+0.435 (+7.57%)

, DVN

Devon Energy

$13.06 /

+0.6 (+4.82%)

, AMCR

Amcor

$9.41 /

+0.58 (+6.57%)

, IFF

IFF

$136.72 /

+4.12 (+3.11%)

, EB

Eventbrite

$7.96 /

-2.555 (-24.31%)

, CVLT

Commvault

$39.46 /

-6 (-13.20%)

The S&P is slightly…

Open Full Text

ShowHide Related Items >><<
UBER Uber
$33.66 /

+2.005 (+6.33%)

RF Regions Financial
$9.69 /

-0.12 (-1.22%)

PNC PNC Financial
$100.09 /

-2.17 (-2.12%)

OKE Oneok
$33.81 /

+2.43 (+7.74%)

MRO Marathon Oil
$6.18 /

+0.435 (+7.57%)

KEY KeyCorp
$10.54 /

-0.17 (-1.59%)

IFF IFF
$136.72 /

+4.12 (+3.11%)

GRUB GrubHub
$62.52 /

+15.7 (+33.53%)

GNFT Genfit
$7.54 /

-14.63 (-65.99%)

FITB Fifth Third
$16.69 /

-0.52 (-3.02%)

EB Eventbrite
$7.96 /

-2.555 (-24.31%)

DVN Devon Energy
$13.06 /

+0.6 (+4.82%)

CVLT Commvault
$39.46 /

-6 (-13.20%)

CMA Comerica
$31.32 /

-0.83 (-2.58%)

CBAY CymaBay
$4.28 /

+2.44 (+132.61%)

BLK BlackRock
$464.17 /

-29.27 (-5.93%)

GRUB GrubHub
$62.52 /

+15.7 (+33.53%)

05/12/20 Needham
Uber deal for GrubHub could accelerate food delivery profitability, says Needham
05/11/20 Deutsche Bank
GrubHub price target raised to $46 from $40 at Deutsche Bank
05/08/20 Barclays
GrubHub price target raised to $55 from $49 at Barclays
05/04/20 Goldman Sachs
Prolonged store closures to hurt Shake Shack sales, says Goldman Sachs
UBER Uber
$33.66 /

+2.005 (+6.33%)

05/08/20
Fly Intel: Top five analyst upgrades
05/08/20 JPMorgan
Uber price target raised to $38 from $32 at JPMorgan
05/08/20 Needham
Uber price target raised to $42 from $36 at Needham
PNC PNC Financial
$100.09 /

-2.17 (-2.12%)

05/12/20 Stephens
PNC Financial upgraded to Overweight from Equal Weight at Stephens
05/04/20 UBS
Wells Fargo, PNC Financial cut to Sell, Keycorp cut to Neutral at UBS
05/04/20 UBS
PNC Financial downgraded to Sell from Neutral at UBS
04/16/20 Nomura Instinet
PNC Financial upgraded to Buy from Neutral at Nomura Instinet
BLK BlackRock
$464.17 /

-29.27 (-5.93%)

04/17/20 BMO Capital
BlackRock price target raised to $441 from $386 at BMO Capital
04/17/20 Barclays
BlackRock price target raised to $515 from $495 at Barclays
04/08/20 Morgan Stanley
Victory Capital downgraded to Underweight at Morgan Stanley
RF Regions Financial
$9.69 /

-0.12 (-1.22%)

04/14/20 Compass Point
Regions Financial initiated with a Neutral at Compass Point
03/19/20 Goldman Sachs
Regions Financial upgraded to Conviction Buy from Buy at Goldman Sachs
03/17/20 Wedbush
Regions Financial added to Best List Ideas at Wedbush
03/09/20 Raymond James
Regions Financial double downgraded at Raymond James as oil prices sink
CMA Comerica
$31.32 /

-0.83 (-2.58%)

04/14/20 Compass Point
Comerica initiated with a Neutral at Compass Point
04/06/20 Wells Fargo
Wells Fargo sees information 'void' until banks report earnings next week
03/26/20 Odeon Capital
Comerica upgraded to Hold from Sell at Odeon Capital
03/19/20 SunTrust
Comerica price target lowered to $40 from $52 at SunTrust
KEY KeyCorp
$10.54 /

-0.17 (-1.59%)

05/04/20 UBS
KeyCorp downgraded to Neutral from Buy at UBS
04/17/20 BofA
KeyCorp downgraded to Neutral from Buy at BofA
04/17/20 BofA
KeyCorp downgraded to Neutral from Buy at BofA
FITB Fifth Third
$16.69 /

-0.52 (-3.02%)

03/23/20 DA Davidson
Fifth Third initiated with a Buy at DA Davidson
03/18/20 Wedbush
Fifth Third/Toll Brothers/Tempur Sealy removed from Best Ideas List at Wedbush
03/02/20 Baird
Baird upgrades Regions Financial, Fifth Third, First Horizon to Outperform
CBAY CymaBay
$4.28 /

+2.44 (+132.61%)

05/12/20
Fly Intel: Top five analyst upgrades
05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
05/12/20 SVB Leerink
CymaBay upgraded to Outperform at SVB Leerink
05/12/20 Roth Capital
CymaBay upgraded to Buy from Neutral at Roth Capital
GNFT Genfit
$7.54 /

-14.63 (-65.99%)

05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
05/12/20 SVB Leerink
Genfit price target lowered to $20 from $50 at SVB Leerink
OKE Oneok
$33.81 /

+2.43 (+7.74%)

05/05/20
Fly Intel: Top five analyst downgrades
05/05/20 Credit Suisse
Oneok downgraded to Neutral from Outperform at Credit Suisse
05/01/20 Mizuho
Oneok price target lowered to $36 from $41 at Mizuho
05/01/20 RBC Capital
Oneok downgraded to Sector Perform from Outperform at RBC Capital
MRO Marathon Oil
$6.18 /

+0.435 (+7.57%)

05/08/20 Susquehanna
Marathon Oil downgraded to Neutral at Susquehanna
05/08/20 Susquehanna
Marathon Oil downgraded to Neutral from Positive at Susquehanna
04/22/20 Credit Suisse
Marathon Oil downgraded to Neutral from Outperform at Credit Suisse
04/15/20 OTR Global
U.S. tank barge shipping market view lowered to mixed at OTR Global
DVN Devon Energy
$13.06 /

+0.6 (+4.82%)

05/06/20 Susquehanna
Devon Energy price target raised to $13 from $12 at Susquehanna
03/25/20 Piper Sandler
Devon Energy downgraded to Neutral from Overweight at Piper Sandler
03/24/20 Piper Sandler
Devon Energy downgraded to Neutral from Overweight at Piper Sandler
03/24/20 SunTrust
Devon Energy price target lowered to $8 from $15 at SunTrust
AMCR Amcor
$9.41 /

+0.58 (+6.57%)

04/23/20 Jefferies
Amcor downgraded to Hold from Buy at Jefferies
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
04/02/20 Deutsche Bank
Amcor price target raised to $9.25 from $7.50 at Deutsche Bank
03/23/20 Jefferies
Amcor upgraded to Buy from Hold at Jefferies
IFF IFF
$136.72 /

+4.12 (+3.11%)

04/29/20 Wells Fargo
IFF upgraded to Overweight from Equal Weight at Wells Fargo
04/20/20 JPMorgan
JPMorgan upgrades DuPont with 45% upside potential by year-end
04/20/20 JPMorgan
DuPont upgraded to Overweight from Neutral at JPMorgan
04/06/20 Exane BNP Paribas
IFF upgraded to Neutral from Underperform at Exane BNP Paribas
EB Eventbrite
$7.96 /

-2.555 (-24.31%)

05/12/20 SunTrust
Eventbrite price target raised to $12 from $8 at SunTrust
04/03/20 SunTrust
Eventbrite price target lowered to $8 from $19 at SunTrust
02/28/20 SunTrust
Eventbrite price target lowered to $19 from $22 at SunTrust
02/28/20 RBC Capital
Eventbrite downgraded to Sector Perform from Outperform at RBC Capital
CVLT Commvault
$39.46 /

-6 (-13.20%)

04/20/20
Fly Intel: Top five analyst initiations
04/20/20 Needham
Commvault initiated with a Buy at Needham
01/15/20 Piper Sandler
Piper introduces long VMware, short Juniper pair trade into Q4 results
10/16/19 Jefferies
Commvault SaaS offering opens up 'meaningful opportunity,' says Jefferies
UBER Uber
$33.66 /

+2.005 (+6.33%)

RF Regions Financial
$9.69 /

-0.12 (-1.22%)

PNC PNC Financial
$100.09 /

-2.17 (-2.12%)

OKE Oneok
$33.81 /

+2.43 (+7.74%)

MRO Marathon Oil
$6.18 /

+0.435 (+7.57%)

KEY KeyCorp
$10.54 /

-0.17 (-1.59%)

IFF IFF
$136.72 /

+4.12 (+3.11%)

GRUB GrubHub
$62.52 /

+15.7 (+33.53%)

FITB Fifth Third
$16.69 /

-0.52 (-3.02%)

EB Eventbrite
$7.96 /

-2.555 (-24.31%)

DVN Devon Energy
$13.06 /

+0.6 (+4.82%)

CVLT Commvault
$39.46 /

-6 (-13.20%)

CMA Comerica
$31.32 /

-0.83 (-2.58%)

CBAY CymaBay
$4.28 /

+2.44 (+132.61%)

BLK BlackRock
$464.17 /

-29.27 (-5.93%)

AMCR Amcor
$9.41 /

+0.58 (+6.57%)

  • 13
    May
RF Regions Financial
$9.69 /

-0.12 (-1.22%)

PNC PNC Financial
$100.09 /

-2.17 (-2.12%)

MRO Marathon Oil
$6.18 /

+0.435 (+7.57%)

KEY KeyCorp
$10.54 /

-0.17 (-1.59%)

IFF IFF
$136.72 /

+4.12 (+3.11%)

GRUB GrubHub
$62.52 /

+15.7 (+33.53%)

GNFT Genfit
$7.54 /

-14.63 (-65.99%)

FITB Fifth Third
$16.69 /

-0.52 (-3.02%)

EB Eventbrite
$7.96 /

-2.555 (-24.31%)

DVN Devon Energy
$13.06 /

+0.6 (+4.82%)

CMA Comerica
$31.32 /

-0.83 (-2.58%)

BLK BlackRock
$464.17 /

-29.27 (-5.93%)

AMCR Amcor
$9.41 /

+0.58 (+6.57%)

UBER Uber
$33.66 /

+2.005 (+6.33%)

RF Regions Financial
$9.69 /

-0.12 (-1.22%)

PNC PNC Financial
$100.09 /

-2.17 (-2.12%)

OKE Oneok
$33.81 /

+2.43 (+7.74%)

MRO Marathon Oil
$6.18 /

+0.435 (+7.57%)

KEY KeyCorp
$10.54 /

-0.17 (-1.59%)

IFF IFF
$136.72 /

+4.12 (+3.11%)

GRUB GrubHub
$62.52 /

+15.7 (+33.53%)

GNFT Genfit
$7.54 /

-14.63 (-65.99%)

FITB Fifth Third
$16.69 /

-0.52 (-3.02%)

DVN Devon Energy
$13.06 /

+0.6 (+4.82%)

CVLT Commvault
$39.46 /

-6 (-13.20%)

CMA Comerica
$31.32 /

-0.83 (-2.58%)

CBAY CymaBay
$4.28 /

+2.44 (+132.61%)

BLK BlackRock
$464.17 /

-29.27 (-5.93%)

UBER Uber
$33.66 /

+2.005 (+6.33%)

RF Regions Financial
$9.69 /

-0.12 (-1.22%)

PNC PNC Financial
$100.09 /

-2.17 (-2.12%)

OKE Oneok
$33.81 /

+2.43 (+7.74%)

MRO Marathon Oil
$6.18 /

+0.435 (+7.57%)

KEY KeyCorp
$10.54 /

-0.17 (-1.59%)

IFF IFF
$136.72 /

+4.12 (+3.11%)

GRUB GrubHub
$62.52 /

+15.7 (+33.53%)

FITB Fifth Third
$16.69 /

-0.52 (-3.02%)

EB Eventbrite
$7.96 /

-2.555 (-24.31%)

DVN Devon Energy
$13.06 /

+0.6 (+4.82%)

BLK BlackRock
$464.17 /

-29.27 (-5.93%)

Downgrade
Genfit downgraded to Neutral from Buy at B. Riley FBR » 12:35
05/12/20
05/12
12:35
05/12/20
12:35
GNFT

Genfit

$7.57 /

-14.6 (-65.85%)

B. Riley FBR analyst…

B. Riley FBR analyst Mayank Mamtani downgraded Genfit to Neutral from Buy with a price target of $9, down from $34, following last night's Phase 3 failure in nonalcoholic steatohepatitis.

ShowHide Related Items >><<
GNFT Genfit
$7.57 /

-14.6 (-65.85%)

GNFT Genfit
$7.57 /

-14.6 (-65.85%)

05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
05/12/20 SVB Leerink
Genfit price target lowered to $20 from $50 at SVB Leerink
05/12/20 Baird
Intercept competitor trial failure a positive, says at Baird
GNFT Genfit
$7.57 /

-14.6 (-65.85%)

GNFT Genfit
$7.57 /

-14.6 (-65.85%)

On The Fly
CymaBay jumps, Genfit plunges as Wall Street digests NASH news » 10:50
05/12/20
05/12
10:50
05/12/20
10:50
CBAY

CymaBay

$4.58 /

+2.74 (+148.91%)

, GNFT

Genfit

$7.70 /

-14.47 (-65.27%)

, ICPT

Intercept

$90.60 /

+0.18 (+0.20%)

Shares of CymaBay (CBAY)…

Open Full Text

ShowHide Related Items >><<
ICPT Intercept
$90.60 /

+0.18 (+0.20%)

GNFT Genfit
$7.70 /

-14.47 (-65.27%)

CBAY CymaBay
$4.58 /

+2.74 (+148.91%)

CBAY CymaBay
$4.58 /

+2.74 (+148.91%)

05/12/20 B. Riley FBR
CymaBay upgraded to Buy from Neutral at B. Riley FBR
05/12/20
Fly Intel: Top five analyst upgrades
05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
05/12/20 SVB Leerink
CymaBay upgraded to Outperform at SVB Leerink
GNFT Genfit
$7.70 /

-14.47 (-65.27%)

05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
05/12/20 Roth Capital
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital
05/12/20 SVB Leerink
Genfit price target lowered to $20 from $50 at SVB Leerink
ICPT Intercept
$90.60 /

+0.18 (+0.20%)

05/12/20 Baird
Intercept competitor trial failure a positive, says at Baird
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
ICPT Intercept
$90.60 /

+0.18 (+0.20%)

CBAY CymaBay
$4.58 /

+2.74 (+148.91%)

ICPT Intercept
$90.60 /

+0.18 (+0.20%)

GNFT Genfit
$7.70 /

-14.47 (-65.27%)

GNFT Genfit
$7.70 /

-14.47 (-65.27%)

CBAY CymaBay
$4.58 /

+2.74 (+148.91%)

ICPT Intercept
$90.60 /

+0.18 (+0.20%)

Recommendations
Genfit price target lowered to EUR 13 from EUR 70 at Roth Capital » 10:28
05/12/20
05/12
10:28
05/12/20
10:28
GNFT

Genfit

$7.99 /

-14.18 (-63.96%)

Roth Capital analyst…

Roth Capital analyst Yasmeen Rahimi lowered the firm's price target on Genfit to EUR 13 from EUR 70 after the company's "highly anticipated" RESOLVE-IT Phase 3 interim data set "shocked" both the analyst and peers in missing on both biopsy-proven endpoints as well as other key metabolic secondary endpoints. Rahimi, who said "it is challenging to visualize" that the FDA and EMA would allow the company to continue the RESOLVE-IT program given this data set, has removed nonalcoholic steatohepatitis from her valuation until further guidance is provided. However, Rahimi keeps a Buy rating on Genfit shares given the view that the company has a path forward in primary biliary cholangitis, or PBC, and bringing its diagnostic kit to the market.

ShowHide Related Items >><<
GNFT Genfit
$7.99 /

-14.18 (-63.96%)

GNFT Genfit
$7.99 /

-14.18 (-63.96%)

05/12/20 Citi
Intercept downgraded to Neutral from Buy at Citi
05/12/20 SVB Leerink
Genfit price target lowered to $20 from $50 at SVB Leerink
05/12/20 Baird
Intercept competitor trial failure a positive, says at Baird
05/12/20 H.C. Wainwright
Genfit downgraded to Neutral from Buy at H.C. Wainwright
GNFT Genfit
$7.99 /

-14.18 (-63.96%)

GNFT Genfit
$7.99 /

-14.18 (-63.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.